Lorraine L. Janeczko
By
Lorraine L. Janeczko
Published: June 1, 2014, 4:59 p.m.·
Tags:
HIV coinfection,
Treatment
Patients coinfected with HIV and tuberculosis (TB) may benefit from raltegravir as an alternative to efavirenz, new research suggests.
Read More →
By
Lorraine L. Janeczko
Published: Feb. 3, 2013, 4:55 p.m.·
Tags:
None
Fixed-dose combination (FDC) formulations simplify TB therapy but are not better for patients, a recent meta-analysis reports.
Read More →
Page 1 of 1 · Total posts: 2
1